CLPTM1L and ovarian carcinoma: We found that CLPTM1L was expressed highly in ovarian cancer, lung cancer and in pancreatic cancer cell lines but not in normal ovarian cell lines, fibroblasts or endothelial cell lines (Fig. 1e).